VERACYTE INC
VERACYTE INC
Share · US92337F1075 · VCYT · A1W7EA (XNMS)
Overview
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
13
6
1
0
No Price
20.03.2026 10:02
Current Prices from VERACYTE INC
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
VCYT
USD
20.03.2026 10:02
32,59 USD
-0,19 USD
-0,58 %
XHAM: Hamburg
Hamburg
VIRSDL75.HAMB
EUR
20.03.2026 07:12
28,20 EUR
-3,40 EUR
-10,76 %
XDQU: Quotrix
Quotrix
VIRSDL75.DUSD
EUR
20.03.2026 06:27
28,40 EUR
-3,20 EUR
-10,13 %
IEXG: IEX
IEX
VCYT
USD
19.03.2026 19:59
32,79 USD
-0,50 USD
-1,49 %
XDUS: Düsseldorf
Düsseldorf
VIRSDL75.DUSB
EUR
19.03.2026 18:30
27,80 EUR
-3,80 EUR
-12,03 %
XFRA: Frankfurt
Frankfurt
12V.F
EUR
27.02.2026 07:09
32,40 EUR
-
Share Float & Liquidity
Free Float 99,45 %
Shares Float 79,02 M
Shares Outstanding 79,46 M
Invested Funds

The following funds have invested in VERACYTE INC:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
118,00
Percentage (%)
0,28 %
Company Profile for VERACYTE INC Share
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
AI Analysis of VERACYTE INC
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of VERACYTE INC
No AI threads available for this company yet.

Company Data

Name VERACYTE INC
Company Veracyte, Inc.
Symbol VCYT
Website https://www.veracyte.com
Primary Exchange XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A1W7EA
ISIN US92337F1075
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Marc A. Stapley
Market Capitalization 3 Mrd.
Country United States of America
Currency USD
Employees 0,8 T
Address 6000 Shoreline Court, 94080 South San Francisco
IPO Date 2013-10-30

Ticker Symbols

Name Symbol
Düsseldorf VIRSDL75.DUSB
Frankfurt 12V.F
Hamburg VIRSDL75.HAMB
NASDAQ VCYT
Quotrix VIRSDL75.DUSD
More Shares
Investors who hold VERACYTE INC also have the following shares in their portfolio:
AKER BP NK 1
AKER BP NK 1 Share
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BEMETALS CORP
BEMETALS CORP Share
CANADIAN PAC KA.CITY LTD.
CANADIAN PAC KA.CITY LTD. Share
CINTAS CORP
CINTAS CORP Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
PILBARA MINERALS
PILBARA MINERALS Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026